The role of a stromal cell-derived factor-1 chemokine gene variant in the clinical course of HIV-1 infection

AIDS

Volumn 12, Issue 9, 1998, Pages

  Van Rij, Ronald P ^a   Broersen, Silvia ^a   Goudsmit, Jaap ^b   Coutinho, Roel A ^b,c   Schuitemaker, Hanneke ^a,d  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c MUNICIPAL HEALTH SERVICE   (Netherlands)

^d CENTRAL LABORATORY   (Netherlands)

Author keywords

CD4 T cells; Disease progression; HIV 1; Kaposi's sarcoma; Stromal cell derived factor 1; Viral phenotype

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; DISEASE COURSE; DNA POLYMORPHISM; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL;

EID: 0032543538     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199809000-00002     Document Type: Article

References (23)

1. Deng HK, Liu R, Ellmeier W, et al.: Identification of the major co-receptor for primary isolates of HIV-1. Nature 1996, 381:661-666.
2. Dragic T, Litwin V, Allaway GP, et al.: HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996, 381:667-673.
3. Alkhatib G, Combadiere C, Broder CC, et al.: CC CKR5: a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996, 272:1955-1958.
4. Choe H, Farzan M, Sun Y, et al.: The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996, 85:1135-1148.
5. Doranz BJ, Rucker J, Yi Y, et al.: A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3 and CKR-2b as fusion cofactors. Cell 1996, 85:1149-1158.
6. Simmons G, Wilkinson D, Reeves JD, et al.: Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either LESTR or CCR5 as co-receptors for virus entry. J Virol 1996, 70:8355-8360.
7. He J, Chen Y, Farzan M, et al.: CCR3 and CCR5 are coreceptors for HIV-1 infection of microglia. Nature 1997, 385:645-649.
8. Samson M, Libert F, Doranz BJ, et al.: Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996, 382:722-725.
9. Liu R, Paxton WA, Choe S, et al.: Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996, 86:1-20
10. Dean M, Carrington M, Winkler C, et al.: Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 1996, 273:1856-1862.
11. Eugen-Olsen J, Iversen AKN, Garred P, et al.: Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals. AIDS 1997, 11:305-310.
12. Michael NL, Chang G, Louie LG, et al.: The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nature Med 1997, 3:338-340.
13. Zimmerman PA, Buckler-White A, Alkhatib G, et al.: Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk. Mol Med 1997, 3:23-36.
14. De Roda Husman AM, Koot M, Cornelissen M, et al.: Association between CCR5 genotype and the clinical course of HIV-1 infection. Ann Intern Med 1997, 127:882-890.
15. Smith MW, Dean M, Carrington M, et al.: Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 1997, 277:959-965.
16. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Callo RC, Lusso P: Identification of RANTES, MIP-1α, and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995, 270:1811-1815.
17. Oberlin E, Amara A, Bachelerie F, et al.: The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line adapted HIV-1. Nature 1996, 382:833-835.
18. Bleul CC, Farzan M, Choe H, et al.: The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 1996, 382:829-832.
19. Amara A, Le Gall S, Schwartz O, et al.: HIV coreceptor downregulation as antiviral principle: SDF-1α-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J Exp Med 1997, 186:139-146.
20. Winkler C, Modi W, Smith MW, et al.: Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. Science 1998, 279:389-393.
21. Koot M, Keet IPM, Vos AHV, et al.: Prognostic value of human immunodeficiency virus type 1 biological phenotype for rate of CD4+ cell depletion and progression to AIDS. Ann Intern Med 1993, 118:681-688.
22. Centers tor Disease Control: Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987, 36 (suppl 1):1S-15S.
23. Centers for Disease Control: 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1993, 41 (RR-17):1-19.